17
Feb
2010
Posted in I - Series C, Q - 1Q10, R - NORTH EAST, X - Device (Cardiology), XX - NJ
CicuLite (Saddle Brook, NJ) a clinical-stage medical device company focused on minimally invasive implantable devices for chronic heart failure, closed a $32.5M Series C financing. Participants include Forbion Capital Partners, Crédit Agricole Private Equity, Foundation Medical Partners and Oxford Bioscience Partners.